Cabaletta Bio, Inc. Common Stock (CABA)
Cabaletta Bio, Inc. Common Stock (CABA) has a 22-report earnings history dating back to Aug 05, 2021. Its average absolute post-earnings move is ±8.68%, and 59.1% of those reactions were positive. Its largest post-earnings gain was +38.46% (May 15, 2025) and its largest decline was -34.64% (Aug 08, 2024). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How CABA moved on each past earnings report.
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±8.68%
Positive %
59.1%
Negative %
40.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 13, 2026 | ☀ PRE | -4.23% | open_in_new |
| May 14, 2026 | ☀ PRE | +0.56% | open_in_new |
| May 04, 2026 | ☀ PRE | +30.38% | open_in_new |
| Mar 23, 2026 | ☀ PRE | -4.41% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±8.68%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260813 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260812 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260812 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260731 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260727 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260723 | open_in_new SEC.gov |
Frequently asked about CABA earnings
When does Cabaletta Bio, Inc. Common Stock report earnings next? expand_more
Cabaletta Bio, Inc. Common Stock (CABA)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CABA stock move after earnings? expand_more
Over 22 reports, CABA has moved an average of ±8.68% the session after earnings, closing higher 59.1% of the time.
What was CABA's biggest post-earnings move? expand_more
CABA's largest post-earnings gain on record was +38.46% on May 15, 2025, and its largest decline was -34.64% on Aug 08, 2024.
Where can I find Cabaletta Bio, Inc. Common Stock's SEC filings? expand_more
All of Cabaletta Bio, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right